vimarsana.com

Latest Breaking News On - Calcifediol overcomes impact - Page 1 : vimarsana.com

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023 - OPKO Health (NASDAQ:OPK)

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ:OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney

United statesCharlesw bishopAkhtar ashfaqLyvonne briggsBruce vossStephena strugnellHealth incDrug administrationAmerican society of nephrologyExchange commissionAmerican societyKidney weekSecondary hyperparathyroidismExtended release calcifediolExhibit hallsb dCalcifediol overcomes impact

OPKO Health to Present New Clinical Data on Rayaldee (ER

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release.

United statesAkhtar ashfaqStephena strugnellBruce vossCharlesw bishopLyvonne briggsHealth incAmerican society of nephrologyDrug administrationExchange commissionAmerican societyKidney weekSecondary hyperparathyroidismExtended release calcifediolExhibit hallsb dCalcifediol overcomes impact

vimarsana © 2020. All Rights Reserved.